Research graph
References from Elevated circulating fibroblast growth factor 23 is associated with acute kidney injury and mortality in coronavirus disease 2019 (COVID-19). Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
2023 · External reference
Leading causes of death in the US during the COVID-19 pandemic, March 2020 to October 2021
10.1001/jamainternmed.2022.2476 · 2022 · External reference
Outcomes among patients hospitalized with COVID-19 and Acute Kidney Injury
10.1053/j.ajkd.2020.09.002 · 2021 · External reference
Regulation of fibroblast growth factor-23 signaling by klotho
10.1074/jbc.c500457200 · 2006 · External reference
Regulation of 25-hydroxyvitamin D-1-hydroxylase and 24-hydroxylase in keratinocytes by PTH and FGF23
10.1111/exd.13760 · 2018 · External reference
Fibroblast growth factor 23 levels are elevated and associated with severe acute kidney injury and death following cardiac surgery
10.1016/j.kint.2015.12.035 · 2016 · External reference
Plasma FGF23 levels increase rapidly after acute kidney injury
10.1038/ki.2013.150 · 2013 · External reference
FGF23 levels in patients with AKI and risk of adverse outcomes
10.2215/cjn.00550112 · 2012 · External reference
High plasma C-terminal FGF23 levels predict poor outcomes in patients with chronic kidney disease superimposed with acute kidney injury
10.1177/2040622320964161 · 2020 · External reference
Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis
10.1056/nejmoa0706130 · 2008 · External reference
The role of kidney injury biomarkers in COVID-19
2022 · External reference
Fibroblast Growth Factor 23 Levels Associate with AKI and Death in Critical Illness
10.1681/asn.2016080836 · 2017 · External reference
KDIGO clinical practice guidelines for acute kidney injury
10.1159/000339789 · 2012 · External reference
Post-COVID-19 syndrome, low-grade inflammation and inflammatory markers: a cross-sectional study
10.1080/03007995.2022.2042991 · 2022 · External reference
Emerging early diagnostic methods for acute kidney injury
10.7150/thno.71064 · 2022 · External reference
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study
10.1016/s0140-6736(20)31189-2 · 2020 · External reference
Intact fibroblast growth factor 23 and fragments in plasma from Gambian children
10.1007/s00198-012-2029-3 · 2013 · External reference
Acute kidney injury in patients hospitalized with COVID-19
10.1016/j.kint.2020.05.006 · 2020 · External reference
The association of acute kidney injury with disease severity and mortality in COVID-19: a systematic review and meta-analysis
2021 · External reference
Fibroblast growth factor 23, iron and inflammation - are they related in early stages of chronic kidney disease?
10.5114/aoms.2016.58647 · 2017 · External reference
Fibroblast growth factor 23 as a predictor of cardiovascular and all-cause mortality in prospective studies
10.1016/j.atherosclerosis.2017.03.042 · 2017 · External reference
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality
10.1681/asn.2010080894 · 2011 · External reference
Klotho as a potential biomarker and therapy for acute kidney injury
10.1038/nrneph.2012.92 · 2012 · External reference
Crosstalk between fibroblast growth factor 23, iron, erythropoietin, and inflammation in kidney disease
10.1097/mnh.0000000000000514 · 2019 · External reference
The role of fibroblast growth Factor 23 in inflammation and anemia
10.3390/ijms20174195 · 2019 · External reference
Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23
10.1161/circulationaha.111.053405 · 2012 · External reference
COVID-19 in patients undergoing chronic kidney replacement therapy and kidney transplant recipients in Scotland: findings and experience from the Scottish renal registry
10.1186/s12882-020-02061-8 · 2020 · External reference
The Novel Coronavirus 2019 epidemic and kidneys
10.1016/j.kint.2020.03.001 · 2020 · External reference
Kidney disease is associated with in-hospital death of patients with COVID-19
10.1016/j.kint.2020.03.005 · 2020 · External reference
Excess death estimates in patients with end-stage renal disease - United States, February-August 2020
10.15585/mmwr.mm7022e2 · 2021 · External reference
